Amy Leclere
Psychiatric/Mental Health · Cedar Rapids, IANPI 1083224844
Payments from drug & device makers
Across 145 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$528
- Teva Pharmaceuticals USA, Inc.$335
- Axsome Therapeutics, Inc.$319
- Johnson & Johnson$302
- Alkermes, Inc.$301
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$284
- plus $607 from 8 others
What the payments were for
- Food & beverage$2,676100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 28 | $528 |
| Teva Pharmaceuticals USA, Inc. | 18 | $335 |
| Axsome Therapeutics, Inc. | 17 | $319 |
| Johnson & Johnson | 19 | $302 |
| Alkermes, Inc. | 17 | $301 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $284 |
| E.r. Squibb & Sons, L.L.C. | 9 | $186 |
| Vanda Pharmaceuticals Inc. | 8 | $148 |
| AbbVie | 5 | $106 |
| Neurocrine Biosciences, Inc. | 5 | $76 |
| Sunovion Pharmaceuticals Inc. | 2 | $42 |
| Bristol Myers Squibb | 1 | $19 |
| Bioxcel Therapeutics, Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $15 |
How this compares
$2,676 in reported general payments places this provider in the 75th percentile of 443 psychiatric/mental health providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluphenazine Hcl | 12 | $696 |
| Trazodone Hcl | 12 | $131 |
| Gabapentin | 12 | $113 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Cedar Rapids
- Jennifer BradleyCedar Rapids$66K
- Amy MorinCedar Rapids$24K
- Abbie KelleyCedar Rapids$7K
- Natasha LashCedar Rapids$6K
- Kristina GatesCedar Rapids$6K
- Daniell DarbyshireCedar Rapids$5K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
- Kama AusbornWaterloo$64K
- Quentin ChambersDes Moines$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.